Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast‐conserving surgery in early breast cancer
Authors:
- 27 December 2006
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 95 (1) , 45-50
Abstract
Background The optimal sequence of chemotherapy (CT) and radiotherapy (RT) remains uncertain after breast-conserving surgery (BCS). The current study was performed to evaluate whether the concurrent RT with CT increases the toxicities. Methods Two hundred and thirty-eight patients with stages I and II breast cancers were prospectively allocated to concurrent CT and RT (n = 133) and sequential CT and RT (n = 105) after BCS. In the sequential group, RT was started after the completion of three cycles of CT and additional three cycles of CT were delivered after RT. Results There was no significant difference in Grade 3 or 4 hematologic toxicities during CT between the two groups. Radiation related adverse effects were not different between the two groups. During the median follow-up period of 42 months (range: 16–60 months), 18 patients (13.5%) of the concurrent group had systemic recurrence of breast cancer, whereas 20 patients (19.1%) of the sequential group had systemic recurrence. Disease-free survival and local recurrence were not different between the two groups. Conclusions Concurrent CT and RT were not associated with increased toxicity and showed reasonable cosmetic results. The current study indicates that concurrent RT and CT after BCS is a feasible treatment modality with an advantage of shortening the treatment time. J. Surg. Oncol. 2007;95:45–50.Keywords
This publication has 20 references indexed in Scilit:
- Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patientsEuropean Journal of Cancer, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002
- Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinomaCancer, 2002
- Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast CancerNew England Journal of Medicine, 1996
- Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer—toxicity and dose modification: A transtasman radiation oncology group multi-institution studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Impact of Administration-Related Factors on Outcome of Adjuvant Chemotherapy for Primary Breast CancerAmerican Journal of Clinical Oncology, 1989
- Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-RoussyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985